MBIO Competitors & Alternatives

Compare Mustang Bio Inc with similar stocks in the same industry

Biotechnology

MBIO

Main Stock
$0.39
-6.34%
Tradestie Score
40
Market Cap
$11.37M
Analyst Upside
+2433.6%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Gene Therapy
Competitive Moat: None
Core Technology Stack: CAR-T platforms, Lentiviral vectors, Autologous cell therapy manufacturing
Major Customers 3
Academic medical centers Clinical trial sites Research hospitals
Critical Suppliers 2
Viral vector CDMOs Contract research organizations
Direct Ecosystem Rivals 3

Top Competitors

219 stocks in Biotechnology
Company Price Market Cap P/E Score Action
CLYM Climb Bio, Inc. Common Stock
$9.94
-4.05%
$133.50M - 45 Compare
SRZN Surrozen, Inc. Common
$32.32
+2.25%
$117.07M - 33 Compare
ANRO Alto Neuroscience Inc.
$27.12
-8.19%
$110.20M - 32 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.02
-2.89%
$84.52M - 53 Compare
FBIO Fortress Biotech, Inc.
$1.71
-9.04%
$76.17M 0.7 49 Compare
IMMX Immix Biopharma, Inc. Common Stock
$7.48
-4.59%
$67.94M - 52 Compare
DARE Dare Bioscience, Inc. Common Stock
$0.58
-11.13%
$28.98M - 44 Compare
PTN PTN
$6.13
-1.69%
$11.10M - 31 Compare
NCNA NuCana plc American Depositary Share
$0.86
-7.46%
$9.27M - 41 Compare
NDRA ENDRA Life Sciences Inc. Common Stock
$4.42
+0.23%
$4.23M - 43 Compare

Data updated: Nov 17, 2026 | Industry: Biotechnology (SIC 2834)

219 stocks in this industry